Trials / Conditions / Chronic Plaque-type Psoriasis
Chronic Plaque-type Psoriasis
6 registered clinical trials studyying Chronic Plaque-type Psoriasis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis NCT04207801 | Aurigene Discovery Technologies Limited | Phase 2 |
| Completed | Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab NCT03553823 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis NCT02074982 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis NCT01828086 | Novartis Pharmaceuticals | Phase 1 |
| Completed | A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis NCT01071252 | Novartis Pharmaceuticals | Phase 2 |
| Completed | AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis NCT00941031 | Novartis Pharmaceuticals | Phase 2 |